Lars Valeur Køber

Lars Valeur Køber

Clinical Professor

Member of:

  • Internal medicine: Cardiology


  1. Published

    Nursing Home Admission and Initiation of Domiciliary Care After Ischemic Stroke – The Importance of Time to Thrombolysis

    Butt, J. H., Kruuse, Christina Rostrup, Kragholm, K., Johnsen, S. P., Kristensen, S. L., Havers-Borgersen, E., Yafasova, A., Østergaard, L., Gislason, Gunnar Hilmar, Torp-Pedersen, Christian, Køber, Lars Valeur & Fosbøl, E. L., Aug 2021, In: Journal of Stroke and Cerebrovascular Diseases. 30, 8, 10 p., 105916.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Dabigatran and the Risk of Staphylococcus aureus Bacteremia: A Nationwide Cohort Study

    Butt, J. H., Fosbøl, E. L., Verhamme, P., Gerds, Thomas Alexander, Iversen, Kasper, Bundgård, Henning, Bruun, Niels Eske, Larsen, A. R., Petersen, A., Andersen, P. S., Skov, R. L., Gislason, Gunnar Hilmar, Torp-Pedersen, Christian, Køber, Lars Valeur & Olesen, J. B., 2021, In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 73, 3, p. 480-486 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Increased 5-year risk of stroke, atrial fibrillation, acute coronary syndrome, and heart failure in out-of-hospital cardiac arrest survivors compared with population controls: A nationwide registry-based study

    Byrne, C., Pareek, M., Krogager, M. L., Ringgren, K. B., Wissenberg, M., Folke, Fredrik, Lippert, F., Gislason, Gunnar Hilmar, Køber, Lars Valeur, Søgaard, P., Lip, G. Y. H., Torp-Pedersen, C. & Kragholm, K., 2021, In: Resuscitation. 169, p. 53-59

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Nationwide cardiovascular disease admission rates during a second COVID-19 lockdown

    Christensen, D. M., Butt, J. H., Fosbøl, E., Køber, Lars Valeur, Torp-Pedersen, Christian, Gislason, Gunnar Hilmar & Phelps, M., 2021, In: American Heart Journal. 241, p. 35-37 3 p.

    Research output: Contribution to journalLetterResearchpeer-review

  5. Published

    Comparison of the three-level and the five-level versions of the EQ-5D

    Christiansen, A. S. J., Møller, M. L. S., Kronborg, C., Haugan, K. J., Køber, Lars Valeur, Højberg, S., Brandes, A., Graff, C., Diederichsen, S. Z., Nielsen, J. B., Krieger, D., Holst, A. G. & Svendsen, J. H., 2021, In: European Journal of Health Economics. 22, p. 621–628

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Incidence of heart valve disease in women treated with the ergot-derived dopamine agonist bromocriptine

    Clausen, M. F., Rørth, R., Torp-Pedersen, Christian, Westergaard, L. M., Weeke, P. E., Gislason, Gunnar Hilmar, Køber, Lars Valeur, Fosbøl, E. & Kristensen, S. L., 2021, In: BMC Cardiovascular Disorders. 21, 1, 10 p., 622.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF

    Curtain, J. P., Docherty, K. F., Jhund, P. S., Petrie, M. C., Inzucchi, S. E., Køber, Lars Valeur, Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Bengtsson, O., Langkilde, A. M., Sjöstrand, M., Solomon, S. D. & McMurray, J. J. V., 2021, In: European Heart Journal. 42, 36, p. 3727-3738 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF

    Dewan, P., Docherty, K. F., Bengtsson, O., Boer, R. A., Desai, A. S., Drozdz, J., Hawkins, N. M., Inzucchi, S. E., Kitakaze, M., Køber, L., Kosiborod, M. N., Langkilde, A. M., Lindholm, D., Martinez, F. A., Merkely, B., Petrie, M. C., Ponikowski, P., Sabatine, M. S., Schou, M., Sjöstrand, M. & 4 others, Solomon, S. D., Verma, S., Jhund, P. S. & Mcmurray, J. J. V., 1 Apr 2021, In: European Journal of Heart Failure. 23, 4, p. 632-643 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Extrapolating Long-term Event-Free and Overall Survival with Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis of a Phase 3 Randomized Clinical Trial

    Docherty, K. F., Jhund, P. S., Claggett, B., Ferreira, J. P., Bengtsson, O., Inzucchi, S. E., Køber, Lars Valeur, Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Sjöstrand, M., Solomon, S. D. & McMurray, J. J. V., 2021, In: JAMA Cardiology. 6, 11, p. 1298-1305

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study

    D’souza, M., Nielsen, Dorte Lisbet, Svane, Inge Marie, Iversen, Kasper, Rasmussen, P. V., Madelaire, C., Fosbøl, E., Køber, Lars Valeur, Gustafsson, Finn, Andersson, C., Gislason, Gunnar Hilmar, Torp-Pedersen, Christian & Schou, Morten, 2021, In: European Heart Journal. 42, 16, p. 1621-1631

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...12 Next

ID: 543423